Phase I/II trial provides evidence of potential efficacy of ovarian cancer vaccine Sep. 2, 1998 No Comments
Available from NIH: immunotoxin for the treatment of ovarian cancer and mesotheliomas Aug. 20, 1998 No Comments
RSS